Mainstream

Axsome Therapeutics Expects Q4 And Fy24 Revenue Marginally Higher Than Consensus

Axsome Therapeutics expects Q4 and FY24 revenue marginally higher than consensus

Axsome Therapeutics expects Q4 and FY24 revenue marginally higher than consensus

Post ContentaxsmRead More

You might also be interested in reading Chesapeake Financial Shares declares $0.16 dividend.

January 13, 2025
In Mainstream